Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system.

Our study provided valuable evidence for health-care professionals to mitigate the risk of quetiapine-associated cardiac AEs based on an extensive analysis of a real-world, large-sample FAERS database, and prioritize cardiac AE signals.